MaaT Pharma to host a KOL webinar on December 17th, 2024, to discuss data and the unmet medical need in acute Graft-versus-Host Disease (aGvHD) Register here. Sustained High Response Rates at ...
Some results have been hidden because they may be inaccessible to you